Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Executive Summary

HHS Secretary Donna Shalala has offered the post of general counsel to Harriet Rabb, currently vice-dean and George Jaffin professor of law and social responsibility at Columbia University Law School. Rabb joined the university faculty in 1971. As the former director of the Clinical Education department, she oversaw student casework in employment rights, education law, and fair housing. Rabb has authored many articles focusing on equal opportunity law and in the 1970s represented a group of women in a publicized sex discrimination suit against the New York Times. She was a member of the Ford Foundation from 1977-1989, sitting also on the board of the NAACP legal and education fund, Asia Watch, and Legal AID. Senate Judiciary/Antitrust Subcommittee Chief Counsel and Staff Director William Corr also reportedly was a candidate for the general counsel post. HHS may have offered Corr the position of deputy general counsel. HHS also is said to have offered the position of assistant secretary for human development services to Mary Jo Bane, currently the commissioner of the New York Department of Social Services. HHS must find a new candidate for assistant secretary for health following the withdrawal of James Mongan, MD. After having tentatively accepted nomination to the post ("The Pink Sheet" Feb. 8, T&G-1), Mongan had second thoughts and submitted a letter Feb. 9 to HHS Secretary Donna Shalala asking that his name be withdrawn "for personal and family reasons." He reportedly did not want to move his family from Kansas City, Mo., maintain a second home in Washington or try to commute between the cities. The Office of Management & Budget has named Nancy-Ann Min to the newly created position of associate director for health care issues. Announced on Feb. 10, the appointment establishes a seventh associate directorship by breaking out health responsibilities from the OMB associate director for human resources, veterans and labor. During the Bush Administration, that position was held by Thomas Scully, who played a key role in including the Medicaid rebate legislation in OBRA 1990. Scully now is an attorney with the Washington firm Patton Boggs & Blow. Min also is a lawyer and since 1991 has worked with the Washington firm Covington & Burling, where she has been working on state and federal issues. Previously she was a commissioner in the Tennessee Human Services Department. She served in the Carter White House on the staff of the assistant to the president for political liaison before earning a Harvard law degree in 1983. After earning her BA from the University of Tennessee, Min, like a number of Clinton Administration appointees, was awarded a Rhodes Scholarship. OMB Director Leon Panetta said in a Feb. 10 press statement that "no issue is a higher priority for the Clinton Administration than giving the nation a health care system that provides quality, affordable care to every American." Min "brings great experience and obvious abilities to this job," Panetta continued, and "she will play a key role as the President and Mrs. Clinton seek to design, enact and implement a plan that controls costs and provides quality care to all."

You may also be interested in...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts